Aurobindo Pharma's share price is trading higher on December 18 despite the recent news of receiving two observations from the United States Food and Drug Administration (USFDA).At 09:22 am, Aurobindo Pharma was quoting at Rs 1,218.95, up Rs 5.50, or 0.45 percent, on the BSE.These observations came after an inspection of the Unit-V API manufacturing facility at Apitoria Pharma, a wholly owned subs...

Stock IdeasThe market corrected by more than one percent for another session and hit a nearly five-month low on November 13, with the overall breadth remaining in the control of bears. A total of 2,222 shares declined, while 266 shares gained on the NSE. The downward pressure may persist in the market, given the strong control exerted by bears over Dalal Street. Below are some trading ideas for th...

Shares of BSE gained over a percent on November 13 after the company reported robust earnings for the quarter ended September 30, 2024. The exchange's net profit zoomed 187% on-year to Rs 347 and consolidated revenue from operations jumped 137% YoY to Rs 746 crore in Q2FY25.Despite the stellar earnings report, Jefferies has issued an 'Underperform' call on BSE, setting a target price of Rs 3,500 p...

Stocks in FocusLet's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, and acquisitions, here’s a quick look at which stocks will be in focus in today's trade:Results TodayEicher Motors, Alkem Laboratories, Apollo Tyres, Vodafone Idea, Astrazeneca Pharma, Brigade Enterprises, Dilip Buildcon, Dishman Carbogen Amcis, Deepak Nitrite,...

Names like BSE, Voltas, Alkem Laboratories, Kalyan Jewellers, and Oberoi Realty will now be a part of the MSCI Global Standard Index following its latest rejig on November 7. The adjustments for the latest rejig are slated for November 25, and India is expected to witness a net inflow of around $2.5 billion in FII passive flows through the rebalance, according to Nuvama Alternative & Quantitative ...